Page last updated: 2024-08-21

2-piperidone and Bone Loss, Osteoclastic

2-piperidone has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Moore, TM; Shoji, M; Snyder, JP; Wu, D; Yamaguchi, M; Zhang, S; Zhu, S	1
Kaneda, A; Koide, N; Umezawa, K; Yokochi, T	1

Other Studies

2 other study(ies) available for 2-piperidone and Bone Loss, Osteoclastic

Article	Year
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis. Cell and tissue research, 2014, Volume: 357, Issue:1 Topics: Animals; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Disease Models, Animal; Female; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Osteoblasts; Osteoclasts; Piperidones; Pyridines; Xenograft Model Antitumor Assays	2014
Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide. International immunopharmacology, 2015, Volume: 25, Issue:1 Topics: Animals; Bone Resorption; Cell Differentiation; Cell Line; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred ICR; NF-kappa B; NFATC Transcription Factors; Oncogene Protein v-akt; Osteoclasts; Piperidones; RANK Ligand; Signal Transduction	2015

Article

Year

Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis.

Cell and tissue research, 2014, Volume: 357, Issue:1

Topics: Animals; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Disease Models, Animal; Female; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Osteoblasts; Osteoclasts; Piperidones; Pyridines; Xenograft Model Antitumor Assays

2014

Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide.

International immunopharmacology, 2015, Volume: 25, Issue:1

Topics: Animals; Bone Resorption; Cell Differentiation; Cell Line; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred ICR; NF-kappa B; NFATC Transcription Factors; Oncogene Protein v-akt; Osteoclasts; Piperidones; RANK Ligand; Signal Transduction

2015